Thoracic Aortic Stent Grafts-Medical Devices Pipeline Assessment, 2017

Thoracic Aortic Stent Grafts-Medical Devices Pipeline Assessment, 2017


  • Products Id :- GDME0346EPD
  • |
  • Pages: 76
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Thoracic Aortic Stent Grafts-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Thoracic Aortic Stent Grafts-Medical Devices Pipeline Assessment, 2017" provides an overview of Thoracic Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Thoracic Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Thoracic Aortic Stent Grafts under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Thoracic Aortic Stent Grafts Overview 6

3 Products under Development 7

3.1 Thoracic Aortic Stent Grafts-Pipeline Products by Stage of Development 7

3.2 Thoracic Aortic Stent Grafts-Pipeline Products by Territory 8

3.3 Thoracic Aortic Stent Grafts-Pipeline Products by Regulatory Path 9

3.4 Thoracic Aortic Stent Grafts-Pipeline Products by Estimated Approval Date 10

3.5 Thoracic Aortic Stent Grafts-Ongoing Clinical Trials 11

4 Thoracic Aortic Stent Grafts-Pipeline Products under Development by Companies 12

4.1 Thoracic Aortic Stent Grafts Companies-Pipeline Products by Stage of Development 12

4.2 Thoracic Aortic Stent Grafts-Pipeline Products by Stage of Development 13

5 Thoracic Aortic Stent Grafts Companies and Product Overview 14

5.1 Bolton Medical Inc Company Overview 14

5.1.1 Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Cook Medical Inc Company Overview 16

5.2.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Evasc Medical Systems Corp Company Overview 19

5.3.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Lombard Medical Technologies Inc. Company Overview 20

5.4.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Medtronic plc Company Overview 21

5.5.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 MicroPort Scientific Corp Company Overview 26

5.6.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 St. Jude Medical LLC Company Overview 29

5.7.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 TriVascular Inc Company Overview 30

5.8.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 W. L. Gore & Associates Inc Company Overview 31

5.9.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 31

6 Thoracic Aortic Stent Grafts- Recent Developments 35

6.1 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 35

6.2 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 36

6.3 Mar 30, 2017: MPSC Announces 2016 Annual Results 36

6.4 Mar 20, 2017: MicroPort Endovascular Attends the Fifth Shangdong (Mount Tai) Aortic Surgery Forum 38

6.5 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 38

6.6 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 39

6.7 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 40

6.8 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 42

6.9 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 43

6.10 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 44

6.11 Dec 30, 2016: MicroPort Endovascular Attends Sixth China Shenzhen International Cardiovascular Disease Forum & China Cardiovascular Surgery Technique and Engineering Conference 45

6.12 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 45

6.13 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 48

6.14 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 49

6.15 Nov 14, 2016: Medtronic to Unveil Data Supporting Endovascular Treatments for Aortic Disease at VEITHsymposium 2016 49

6.16 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 52

6.17 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 52

6.18 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 53

6.19 Sep 20, 2016: Medtronic Valiant Captivia Demonstrates Safety and Efficacy at Three Years 55

6.20 Sep 19, 2016: First Implant Completed in Pivotal Study of GORE TAG Thoracic Branch Endoprosthesis 56

6.21 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 57

6.22 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 58

6.23 Aug 30, 2016: MPSC Announces 2016 Interim Results 58

6.24 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 60

6.25 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 62

6.26 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 63

6.27 Jul 26, 2016: Merit Medical Announces Appointment of New Director 64

6.28 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 64

6.29 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 66

6.30 Jun 21, 2016: FDA Approves Study of New Aneurysm Device Developed by Sanford Health 66

6.31 Jun 08, 2016: First Patient Treated with Medtronic Valiant Evo Thoracic Stent Graft System 67

6.32 Jun 08, 2016: Market-leading TEVAR Device is First to Surpass 100,000 Devices Distributed Worldwide 68

6.33 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 69

6.34 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 69

7 Appendix 73

7.1 Methodology 73

7.2 About GlobalData 76

7.3 Contact Us 76

7.4 Disclaimer 76

1.2 List of Figures

Figure 1: Thoracic Aortic Stent Grafts-Pipeline Products by Stage of Development 7

Figure 2: Thoracic Aortic Stent Grafts-Pipeline Products by Territory 8

Figure 3: Thoracic Aortic Stent Grafts-Pipeline Products by Regulatory Path 9

Figure 4: Thoracic Aortic Stent Grafts-Pipeline Products by Estimated Approval Date 10

Figure 5: Thoracic Aortic Stent Grafts-Ongoing Clinical Trials 11

1.1 List of Tables

Table 1: Thoracic Aortic Stent Grafts-Pipeline Products by Stage of Development 7

Table 2: Thoracic Aortic Stent Grafts-Pipeline Products by Territory 8

Table 3: Thoracic Aortic Stent Grafts-Pipeline Products by Regulatory Path 9

Table 4: Thoracic Aortic Stent Grafts-Pipeline Products by Estimated Approval Date 10

Table 5: Thoracic Aortic Stent Grafts-Ongoing Clinical Trials 11

Table 6: Thoracic Aortic Stent Grafts Companies-Pipeline Products by Stage of Development 12

Table 7: Thoracic Aortic Stent Grafts-Pipeline Products by Stage of Development 13

Table 8: Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: Relay Thoracic Stent Graft With Plus Delivery System-Product Status 14

Table 10: Relay Thoracic Stent Graft With Plus Delivery System-Product Description 15

Table 11: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Table 12: Zenith TX2 LP TAA Endovascular Graft-Product Status 16

Table 13: Zenith TX2 LP TAA Endovascular Graft-Product Description 16

Table 14: Cook Medical Inc-Ongoing Clinical Trials Overview 17

Table 15: Zenith TX2 LP TAA Endovascular Graft-Evaluation of All-Cause Mortality and Pulmonary Morbidity in Treating Juxtarenal, Suprarenal and Thoracoabdominal Aortic Pathologies Using the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft and Surgeon-Modified Endografts 18

Table 16: Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 19

Table 17: TAS System-Product Status 19

Table 18: TAS System-Product Description 19

Table 19: Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 20

Table 20: TEVAR-Product Status 20

Table 21: TEVAR-Product Description 20

Table 22: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 21

Table 23: Unitary Manifold Stent Graft System-Product Status 21

Table 24: Unitary Manifold Stent Graft System-Product Description 22

Table 25: Valiant EVO-Product Status 22

Table 26: Valiant EVO-Product Description 22

Table 27: Valiant Mona LSA System-Product Status 23

Table 28: Valiant Mona LSA System-Product Description 23

Table 29: Medtronic plc-Ongoing Clinical Trials Overview 24

Table 30: Valiant EVO-Valiant Evo International Clinical Trial 25

Table 31: Valiant EVO-Valiant Evo US Clinical Trial 25

Table 32: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Table 33: Castor Branched Aortic Stent Graft System-Product Status 26

Table 34: Castor Branched Aortic Stent Graft System-Product Description 27

Table 35: Hercules-T-Product Status 27

Table 36: Hercules-T-Product Description 27

Table 37: Next Generation TAA-Product Status 28

Table 38: Next Generation TAA-Product Description 28

Table 39: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29

Table 40: Amplatzer TAA Vascular Graft-Product Status 29

Table 41: Amplatzer TAA Vascular Graft-Product Description 29

Table 42: TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Table 43: Ovation Thoracic Stent Graft System-Product Status 30

Table 44: Ovation Thoracic Stent Graft System-Product Description 30

Table 45: W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 46: GORE TAG Thoracic Branch Endoprosthesis-Product Status 31

Table 47: GORE TAG Thoracic Branch Endoprosthesis-Product Description 31

Table 48: W. L. Gore & Associates Inc-Ongoing Clinical Trials Overview 32

Table 49: GORE TAG Thoracic Branch Endoprosthesis-Evaluation of the GORE TAG Thoracic Branch Endoprosthesis (Branched TAG Device) in the Treatment of Aortic Arch Aneurysms 33

Table 50: GORE TAG Thoracic Branch Endoprosthesis-Evaluation of the GORE TAG Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta 33

Table 51: GORE TAG Thoracic Branch Endoprosthesis-Evaluation of the Gore Tag Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta 33

Table 52: GORE TAG Thoracic Branch Endoprosthesis-Evaluation of the GORE TAG Thoracic Branch Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms 34

Table 53: GORE TAG Thoracic Branch Endoprosthesis-GORE TAG Thoracic Branch Endoprosthesis Early Feasibility Study 34

Table 54: GORE TAG Thoracic Branch Endoprosthesis-Pivotal Study of GORE TAG Thoracic Branch Endoprosthesis 34

Table 55: Glossary 75

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Bolton Medical Inc, Cook Medical Inc, Evasc Medical Systems Corp, Lombard Medical Technologies Inc., Medtronic plc, MicroPort Scientific Corp, St. Jude Medical LLC, TriVascular Inc, W. L. Gore & Associates Inc

Bolton Medical Inc, Relay Thoracic Stent Graft With Plus Delivery System; Cook Medical Inc, Zenith TX2 LP TAA Endovascular Graft; Evasc Medical Systems Corp, TAS System; Lombard Medical Technologies Inc., TEVAR; Medtronic plc, Unitary Manifold Stent Graft System; Medtronic plc, Valiant EVO; Medtronic plc, Valiant Mona LSA System; MicroPort Scientific Corp, Castor Branched Aortic Stent Graft System; MicroPort Scientific Corp, Hercules-T; MicroPort Scientific Corp, Next Generation TAA; St. Jude Medical LLC, Amplatzer TAA Vascular Graft; TriVascular Inc, Ovation Thoracic Stent Graft System; W. L. Gore &; Associates Inc, GORE TAG Thoracic Branch Endoprosthesis

select a license

Single User License
USD 2500 INR 161900
Site License
USD 5000 INR 323800
Corporate User License
USD 7500 INR 485700

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com